U.S. hedge fund files lawsuit accusing Theranos of fraud

(Reuters) - A San Francisco-based hedge fund has filed a lawsuit against Theranos Inc, accusing the blood testing company of using fraudulent methods to attract an investment of nearly $100 million, according to an investor letter filed by the fund.